Evidence map›Paper›PMID 34576229›Full record

ArticleInternational journal of molecular sciences2021

Methyl Brevifolincarboxylate Attenuates Free Fatty Acid-Induced Lipid Metabolism and Inflammation in Hepatocytes through AMPK/NF-κB Signaling Pathway.

Madamanchi Geethangili, Chiao-Wei Lin, Harry J Mersmann, Shih-Torng Ding

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Frontiers in pharmacology · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Global Trends of Lipid Metabolism Research in Epigenetics Field: A Bibliometric Analysis from 2012-2021.International journal of environmental research and public health · 2023
    Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Madamanchi GeethangiliDepartment of Animal Science and Technology, National Taiwan University, Taipei 10672, Taiwan.
Chiao-Wei LinDepartment of Animal Science and Technology, National Taiwan University, Taipei 10672, Taiwan.
Harry J MersmannDepartment of Animal Science and Technology, National Taiwan University, Taipei 10672, Taiwan.
Shih-Torng DingDepartment of Animal Science and Technology, National Taiwan University, Taipei 10672, Taiwan.ORCID 0000-0002-9866-1776
National Taiwan University of Science and Technology · TW

Funding

Ministry of Science and Technology, Taiwan MOST-109-2811-B-002-581
6 · The paper itself

Abstract

The prevalence of non-alcoholic fatty liver disease (NAFLD) is one of the leading causes of chronic liver diseases worldwide. This study examined the potential protective effects of a naturally occurring polyphenolic compound, methyl brevifolincarboxylate (MBC) on fatty liver injury in vitro. The results showed that MBC at its non-cytotoxic concentrations, reduced lipid droplet accumulation and triglyceride (TG) levels in the oleic acid (OA)-treated human hepatocarcinoma cell line, SK-HEP-1 and murine primary hepatocytes. In OA-treated SK-HEP-1 cells and primary murine hepatocytes, MBC attenuated the mRNA expression levels of the de novo lipogenesis molecules, acetyl-coenzyme A carboxylase (

Indexed as

Lipid MetabolismAMP-Activated Protein KinasesAnimalsBenzopyransCell Line, TumorFatty Acids, NonesterifiedHepatocytesHumansInflammationLipidsMaleMiceMice, Inbred C57BLNF-kappa BOleic AcidPhyllanthusAMP-Activated Protein KinasesBenzopyransFatty Acids, NonesterifiedLipidsmethyl brevifolincarboxylateNF-kappa BOleic AcidReactive Oxygen SpeciesTriglyceridesde novo lipogenesisinflammationlipid oxidationmethyl brevifolincarboxylateNAFLDTG

Identifiers

PMID34576229
PMCPMC8469305
OpenAlexW3199268713

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.